Chloroquine cardiomyopathy: beyond ocular adverse effects

BMJ Case Rep. 2014 Sep 15:2014:bcr2014205751. doi: 10.1136/bcr-2014-205751.

Abstract

A 36-year-old woman who had received long-term treatment with chloroquine for systemic lupus erythematosus developed a third degree atrioventricular block and required a permanent pacemaker. Notably, left ventricular thickening and mild systolic dysfunction were noticed on echocardiography as well as on cardiac MRI. As there was no clear explanation for myocardial findings, the patient underwent an endomyocardial biopsy that demonstrated vacuolar degeneration of myocytes on light microscopy and curvilinear bodies on electron microscopy, both findings consistent with chloroquine toxicity. The drug was withheld and treatment with candesartan and carvedilol was prescribed. At 2-year follow-up, the patient remained asymptomatic and left ventricular systolic function had improved. Physicians who prescribe antimalarial drugs for rheumatic diseases should be aware of the potentially life-threatening effects of chloroquine on the heart.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antimalarials / adverse effects*
  • Atrioventricular Block / chemically induced*
  • Cardiomyopathies / chemically induced*
  • Chloroquine / adverse effects*
  • Female
  • Heart Ventricles / drug effects*
  • Heart Ventricles / pathology
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy
  • Ventricular Dysfunction, Left / etiology*

Substances

  • Antimalarials
  • Chloroquine